HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $24,843,000 | +34.4% | 939,973 | -0.6% | 2.91% | +37.5% |
| Q4 2018 | $18,486,000 | +3.0% | 946,060 | +3.2% | 2.11% | +17.5% |
| Q3 2018 | $17,956,000 | -33.6% | 917,051 | -43.8% | 1.80% | -35.0% |
| Q2 2018 | $27,029,000 | -5.2% | 1,632,212 | -18.7% | 2.77% | -21.3% |
| Q1 2018 | $28,502,000 | -0.1% | 2,007,212 | +2.7% | 3.51% | -8.9% |
| Q4 2017 | $28,542,000 | -25.1% | 1,954,912 | -35.0% | 3.86% | -20.8% |
| Q3 2017 | $38,127,000 | +32.6% | 3,006,862 | +24.1% | 4.87% | +17.9% |
| Q2 2017 | $28,750,000 | +11.1% | 2,422,090 | +38.3% | 4.13% | +0.7% |
| Q1 2017 | $25,885,000 | +128.5% | 1,751,322 | +150.2% | 4.10% | +88.8% |
| Q4 2016 | $11,326,000 | -99.8% | 700,000 | +91.8% | 2.17% | +106.6% |
| Q3 2016 | $6,617,450,000 | +108489.6% | 365,000 | -1.4% | 1.05% | -2.9% |
| Q2 2016 | $6,094,000 | +83.9% | 370,000 | +85.0% | 1.08% | +64.4% |
| Q1 2016 | $3,314,000 | +4.7% | 200,000 | +37.0% | 0.66% | +37.7% |
| Q4 2015 | $3,164,000 | – | 146,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |